FdaApplication
NDA 020616
Identifiers
- fda_app_no: NDA020616
Properties
| Property | Value |
|---|---|
| applicant_name | ALLERGAN SALES LLC |
| application_type | NDA |
| approval_date | 1996-07-03 |
Products (12)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| KADIAN | MORPHINE SULFATE | 10MG | CAPSULE, EXTENDED RELEASE;ORAL |
| KADIAN | MORPHINE SULFATE | 70MG | CAPSULE, EXTENDED RELEASE;ORAL |
| KADIAN | MORPHINE SULFATE | 80MG | CAPSULE, EXTENDED RELEASE;ORAL |
| KADIAN | MORPHINE SULFATE | 50MG | CAPSULE, EXTENDED RELEASE;ORAL |
| KADIAN | MORPHINE SULFATE | 40MG | CAPSULE, EXTENDED RELEASE;ORAL |
| KADIAN | MORPHINE SULFATE | 100MG | CAPSULE, EXTENDED RELEASE;ORAL |
| KADIAN | MORPHINE SULFATE | 150MG | CAPSULE, EXTENDED RELEASE;ORAL |
| KADIAN | MORPHINE SULFATE | 200MG | CAPSULE, EXTENDED RELEASE;ORAL |
| KADIAN | MORPHINE SULFATE | 130MG | CAPSULE, EXTENDED RELEASE;ORAL |
| KADIAN | MORPHINE SULFATE | 30MG | CAPSULE, EXTENDED RELEASE;ORAL |
| KADIAN | MORPHINE SULFATE | 20MG | CAPSULE, EXTENDED RELEASE;ORAL |
| KADIAN | MORPHINE SULFATE | 60MG | CAPSULE, EXTENDED RELEASE;ORAL |
12 products